Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)
Completed · Phase 4
Conditions studied: MELAS Syndrome
In brief
This pilot clinical study evaluated the safety and metabolic responses to a licensed inactivated seasonal influenza vaccine (TIV) in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) volunteers and controls.
Key facts
- Study ID
- NCT01831934
- Run by
- Stanford University
- People needed
- 22
- Starts
- 2010-09-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2017-05-30
Who can join
Age: 13 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.